Matches in Nanopublications for { ?s ?p "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP758853.RATyMNOF9J73Ocx-6ZTVMa9Xel_aOwgeWsLjqq2m6i2zo130_assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758853.RATyMNOF9J73Ocx-6ZTVMa9Xel_aOwgeWsLjqq2m6i2zo130_provenance.
- NP995226.RARYV7aG1Cytpl8nqXRC7vtlpLwclMeDig0gKhQ2KVUnk130_assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995226.RARYV7aG1Cytpl8nqXRC7vtlpLwclMeDig0gKhQ2KVUnk130_provenance.
- assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1047420.RAAVj3GC0WkzlZvlruS-j6D9LeIpVmif5nkuCpE5Z4jro130_assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047420.RAAVj3GC0WkzlZvlruS-j6D9LeIpVmif5nkuCpE5Z4jro130_provenance.
- NP1047423.RAiptcZqrOzdS07MVsKcIvLCPxxWwJAYAyY-JL4dijbWc130_assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047423.RAiptcZqrOzdS07MVsKcIvLCPxxWwJAYAyY-JL4dijbWc130_provenance.
- NP1047419.RA0aBLp1JTf7u6fsd_gYAPc8u45kv0paRGS8miMAkv7NE130_assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047419.RA0aBLp1JTf7u6fsd_gYAPc8u45kv0paRGS8miMAkv7NE130_provenance.
- NP1047422.RA5Go_sXrvGSWw6iUInUvYHI9N1MGpPHW5ZiXknTyFwxo130_assertion description "[Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047422.RA5Go_sXrvGSWw6iUInUvYHI9N1MGpPHW5ZiXknTyFwxo130_provenance.